Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy

Area of Science:

• Biomaterials Science
• Immunology
• Drug Delivery

Background:

• Biomedical applications require materials with facile synthesis, tunable degradation, processability, and biocompatibility.
• Current materials like poly(lactic-co-glycolic acid) and iron oxide have limitations in particulate immunotherapy.
• Optimizing material properties is crucial for enhancing antigen presentation and immune responses.

Purpose of the Study:

• To develop a novel biocompatible material, acetalated dextran, for biomedical applications.
• To investigate the tunability of degradation rates in acetalated dextran microparticles.
• To compare the efficacy of acetalated dextran with existing materials in antigen presentation assays.

Main Methods:

• Synthesis of acetalated dextran with varying degrees and types of acetal modification.
• Fabrication of microparticles from acetalated dextran.
• Evaluation of degradation rates and biocompatibility.
• Assessment of major histocompatibility complex class I (MHC I) and MHC II presentation using established assays.

Main Results:

• Acetalated dextran microparticles exhibited degradation rates tunable over two orders of magnitude.
• These particles demonstrated superior performance in MHC I and MHC II presentation assays compared to poly(lactic-co-glycolic acid) and iron oxide.
• Material property modulation enabled antigen presentation on MHC I via both transporter associated with antigen processing-dependent and -independent pathways.

Conclusions:

• Acetalated dextran is a versatile biomaterial with tunable degradation properties for advanced biomedical applications.
• This material offers enhanced antigen presentation capabilities, outperforming current standards in immunotherapy.
• It represents a unique platform for modulating immunological pathways and maximizing immune presentation.